PE20020373A1 - Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones - Google Patents

Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Info

Publication number
PE20020373A1
PE20020373A1 PE2001000889A PE2001000889A PE20020373A1 PE 20020373 A1 PE20020373 A1 PE 20020373A1 PE 2001000889 A PE2001000889 A PE 2001000889A PE 2001000889 A PE2001000889 A PE 2001000889A PE 20020373 A1 PE20020373 A1 PE 20020373A1
Authority
PE
Peru
Prior art keywords
flavor
compositions
lopinavir
flavoring
water
Prior art date
Application number
PE2001000889A
Other languages
English (en)
Inventor
Laman Alani
Donald P Gauwitz
John M Lipari
Kennan C Marsh
Vanik D Petrossian
Richard H Whelan
Soumojeet Ghosh
Dilip Kaul
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20020373A1 publication Critical patent/PE20020373A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)

Abstract

SE REFIERE UNA COMPOSICION LIQUIDA QUE COMPRENDE a)SISTEMA SABORIZANTE QUE COMPRENDE: i)DE 20% A 67% DE EDULCORANTES COMO JARABE DE MAIZ DE ALTA FRUCTOSA; ii)DE 1,4% A 3,5% DE INGREDIENTES SABORIZADOS COMO CRISTALES DE MENTOL, ACEITE DE MENTA, VAINILLA, SABOR A ALGODON DE AZUCAR, CARAMELO, iii)MODIFICADORES DEL SABOR COMO CITRATO DE SODIO, CLORURO DE SODIO, ACIDO CITRICO, b)AGENTES FARMACEUTICOS ACTIVOS COMO LOPINAVIR, RITONAVIR c)UN SISTEMA DE SOLVENTES QUE COMPRENDE SOLUBILIZANTES COMO AGUA, ALCOHOLES ALQUILICOS (ETANOL), ALQUILENGLICOLES (PROPILENGLICOL); d)UN AGENTE ESPESANTE COMO POLIVINILPIRROLIDONA; e)MEJORADOR DE LA BIODISPONIBILIDAD COMO DERIVADO DE ACEITE DE CASTOR. TAMBIEN SE REFIERE A UN PROCESO PARA LA PREPARACION. LOS SISTEMAS SABORIZANTES PUEDEN MEJORAR LAS COMPOSICIONES LIQUIDAS QUE CONTIENEN RITONAVIR O LOPINAVIR QUE SON PRACTICAMENTE INSOLUBLES EN AGUA Y TIENDEN A TENER UN SABOR AMARGO
PE2001000889A 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones PE20020373A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65519200A 2000-09-05 2000-09-05

Publications (1)

Publication Number Publication Date
PE20020373A1 true PE20020373A1 (es) 2002-05-13

Family

ID=24627898

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000889A PE20020373A1 (es) 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Country Status (10)

Country Link
EP (1) EP1315487A2 (es)
JP (1) JP2004522698A (es)
AR (1) AR030715A1 (es)
AU (1) AU2001288695A1 (es)
BR (1) BR0108433A (es)
CA (1) CA2417258A1 (es)
MX (1) MXPA03001952A (es)
PE (1) PE20020373A1 (es)
UY (1) UY26925A1 (es)
WO (1) WO2002020057A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE329579T1 (de) 1999-11-12 2006-07-15 Abbott Lab Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
AU2003295589A1 (en) * 2002-11-22 2004-06-18 Noville, Inc. Oral compositions which mask the salty taste of salts
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
JPWO2013129436A1 (ja) * 2012-02-29 2015-07-30 武田薬品工業株式会社 経口剤
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
AU3146997A (en) * 1996-06-03 1998-01-05 Merck & Co., Inc. Pediatric formulation for hiv protease inhibitors

Also Published As

Publication number Publication date
JP2004522698A (ja) 2004-07-29
UY26925A1 (es) 2002-04-26
AR030715A1 (es) 2003-09-03
AU2001288695A1 (en) 2002-03-22
BR0108433A (pt) 2006-06-06
EP1315487A2 (en) 2003-06-04
MXPA03001952A (es) 2003-09-10
WO2002020057A2 (en) 2002-03-14
CA2417258A1 (en) 2002-03-14
WO2002020057A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
CN101621997B (zh) 医药组合物
PE20020373A1 (es) Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
EP1543826B1 (en) Concentrated aqueous solution of ambroxol
EP0315332B1 (en) Antitussive liquid compositions containing phenol
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
JPH10502616A (ja) Ｄｘ−５２−１化合物の安定化法及びその凍結乾燥組成物
JP2003128583A (ja) 清涼化組成物
US7429390B2 (en) Stable pharmaceutical compositions, processes for making the same and methods of their use
ES2310550T3 (es) Preparacion liquida acuosa de pranoprofeno.
US6194462B1 (en) Pharmaceutical preparation containing nimesulide for oral administration
US11135162B2 (en) Pharmaceutical composition in the form of an aqueous solution, 1A syrup, containing inosine pranobex and zinc gluconate and a method of preparation thereof
CA1253160A (en) Pharmaceutical salts of 4'-(9-acridinylamino) methanesulfon-manisidide
US6660743B1 (en) Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
US4406888A (en) Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
JPH1135489A (ja) ポリオキシエチレン硬化ヒマシ油類の分解を防止した液剤
JPH09286723A (ja) 改善された経口液剤
JP2007008852A (ja) プラバスタチンを含有する水性製剤の安定化方法
ES2238418T3 (es) Solucion acuosa estable de desoxifructosazina.
JP3990728B2 (ja) Ｎ−［４−オキソ−２−（１ｈ−テトラゾール−５−イル）−４ｈ−１−ベンゾピラン−８−イル］−４−（４−フェニルブトキシ）ベンズアミドの塩
JP3027696B2 (ja) 安定な水性医薬組成物
JP2003055247A (ja) 内服用液剤
JPH0733666A (ja) インドロカルバゾール誘導体の安定化法
GB1397893A (en) Pharmaceutical compositions
TH51212A (th) ระบบแต่งรสชาติสำหรับองค์ประกอบทางเภสัชกรรมและวิธีการเตรียมองค์ประกอบดังกล่าว

Legal Events

Date Code Title Description
FX Voluntary withdrawal